AM-A from Koidz induces unique cell death in breast cancer cells through specific pathways, showing potential as a lead compound for therapeutic development.
Scientists tested the compound sesquilignans on liver cancer cells. It significantly inhibited cell growth, induced cell death processes, and activated specific cell signaling pathways. This study demonstrates sesquilignans' potential as an anticancer agent through multiple mechanisms.
Curcumin, a compound in turmeric, shows promise as a potent anticancer agent. Nanospheres provide an effective delivery method for curcumin, improving targeting and efficacy in cancer treatment, with minimal side effects.
New species of Lactuca (L. anatolica) showed stronger antioxidant properties compared to L. sativa (LS). Both inhibited cancer cell growth and induced apoptosis, suggesting pharmacological potential for further research.
Moringa seed extract has potent anticancer, anti-inflammatory, antioxidant, and antibacterial properties. It induces apoptosis, cell cycle arrest, and upregulates tumor-suppressing proteins while being safe for normal cells. It shows promise for developing selective cancer treatment drugs.
Researchers studied the fruit of for potential cancer-fighting properties. Extracts showed cytotoxic effects on colorectal cancer cells, inducing programmed cell death. Identified 71 metabolites with anticancer properties. This study supports the medicinal potential of fruit extracts for cancer treatment.
Plant-derived extracellular nanovesicles (CLENs) inhibit TNBC cell growth and migration by targeting PI3K/AKT and MAPK/ERK pathways. Promising natural anti-cancer agents for TNBC treatment.
AC medicinal plants have promising effects on colon cancer therapy due to their impact on gut microbiome and bile acid metabolism. Understanding their mechanisms can lead to improved treatment strategies for digestive tract tumors.